Dynamic changes of bone metastasis predict bone-predominant status to benefit from radium-223 dichloride for patients with castration-resistant prostate cancer.
Hashimoto K, Miyoshi Y, Shindo T, Hori M, Tsuboi Y, Kobayashi K, Fukuta F, Tanaka T, Miyamoto S, Maehana T, Okada M, Nishiyama N, Yanase M, Kato R, Hotta H, Kunishima Y, Takahashi A, Hinotsu S, Sakata KI, Kitamura H, Uemura H, Masumori N.
Hashimoto K, et al. Among authors: miyamoto s.
Cancer Med. 2020 Nov;9(22):8579-8588. doi: 10.1002/cam4.3459. Epub 2020 Sep 22.
Cancer Med. 2020.
PMID: 32964674
Free PMC article.